From GRP to SIUU – the Evolution of FDA Guidance on Off-Label Dissemination of Scientific Information
FDA Law Blog
OCTOBER 24, 2023
Previous iterations of this guidance from 2009 and 2014 (blogged on here and here ) were known as Good Reprint Practices (GRP). Creation of a “Safe Harbor” for Firm-Generated Presentations of Scientific Information FDA acknowledges that firms may develop presentations of scientific information from an accompanying reprint.
Let's personalize your content